Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125410492 | 12541049 | 2 | F | 201605 | 20160729 | 20160708 | 20160729 | EXP | AR-ABBVIE-16P-007-1670840-00 | ABBVIE | 75.76 | YR | M | Y | 54.50000 | KG | 20160729 | MD | COUNTRY NOT SPECIFIED | AR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125410492 | 12541049 | 1 | PS | ZEMPLAR | PARICALCITOL | 1 | Intravenous (not otherwise specified) | 542048E02 | 20819 | 5 | UG | INJECTION | TIW |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125410492 | 12541049 | 1 | Hyperparathyroidism secondary |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125410492 | 12541049 | OT |
| 125410492 | 12541049 | DE |
| 125410492 | 12541049 | LT |
| 125410492 | 12541049 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125410492 | 12541049 | Bradyarrhythmia | |
| 125410492 | 12541049 | Cardio-respiratory arrest | |
| 125410492 | 12541049 | Colon cancer | |
| 125410492 | 12541049 | Gastrointestinal haemorrhage | |
| 125410492 | 12541049 | General physical health deterioration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125410492 | 12541049 | 1 | 20150818 | 0 |